Quality of life as an outcome measure for epilepsy clinical trials

Pharmacy World and Science

Volumn 19, Issue 5, 1997, Pages 227-230

  Cramer, Joyce A ^a  

^a VA CONNECTICUT HEALTHCARE SYSTEM   (United States)

Author keywords

Antiepileptic drugs; Clinical trials; Epilepsy; Pharmacoeconomics; Quality of life

Indexed keywords

ANTICONVULSIVE AGENT;

ARTICLE; CLINICAL TRIAL; COST; EDUCATION; EPILEPSY; HUMAN; PHARMACOECONOMICS; QUALITY OF LIFE; TREATMENT OUTCOME;

ANTICONVULSANTS; AUTOMOBILE DRIVING; COGNITION; COST-BENEFIT ANALYSIS; DRUG EVALUATION; EMPLOYMENT; EPILEPSY; FAMILY RELATIONS; GUIDELINES; HUMANS; MEMORY; PHYSICAL FITNESS; QUALITY OF LIFE; SOCIOECONOMIC FACTORS; TREATMENT OUTCOME;

EID: 0030825167     PISSN: 09281231     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1008607109347     Document Type: Article

References (31)

1. Cramer JA, Smith DB, Mattson RH, et al. A method for quantification for the evaluation of antiepileptic drugs in adults. Neurology 1983;33(Suppl. 1. 1): S26-S37.
2. Duncan JS, Sander JWAS. The Chalfont seizure severity scale. J Neurol Neurosurg Psychiatry 1991;54: 973-876.
3. Baker GA, Smith DF, Morrow J, Crawford PM, Chadwick DW. The development of a seizure severity scale as an outcome measure in epilepsy. Epil Res 1991;8: 245-51.
4. Aldenkamp AP, Baker GA, Pieters MSM, Schoemaker HC, Cohen AF, Schwabe S. The Neurotoxicity Scale: The validity of a patient-based scale, assessing neurotoxicity. Epil Res 1995; 20: 29-39.
5. Cramer, JA. Quality of life for people with epilepsy, Neurologic Clinics: Epilepsy II: Special Issues, ed. O Devinsky, WB Saunders Company, New York, 1994A;12: 1-13.
6. World Health Organization. The first 10 years of the World Health Organization. Geneva: WHO, 1958.
7. Schipper H, Clinch J, Powell, V. Definitions and conceptual issues. In: Spilker B, ed. Quality of Life Assessments in Clinical Trials. New York: Raven Press, 1990: 11-24.
8. Perrine K, Hermann BP, Meador KJ, Vickrey BG, Cramer JA, Hays RD, Devinsky O. The relationship of neuropsychological functioning to quality of life in epilepsy. Arch Neurol 1995; 52: 997-1003.
9. Hermann BP, Whitman S. Behavioral and personality correlates of epilepsy: a review, methodological critique, and conceptual model. Psychol Bull 1984;95: 451-97.
10. Jacoby A. Epilepsy and the quality of everyday life: findings from a study of people with well- controlled epilepsy. Soc Sci Med 1992;34: 657-66.
11. Cramer JA. Quality of Life Assessments in Epilepsy. In: Spilker B, ed. Quality of Life and Pharmacoeconomics in Clinical Trials, Philadelphia: Lippincott-Raven Publishers, 1996: 909-18.
12. Spilker B. Quality of Life and Pharmacoeconomics in Clinical Trials, Philadelphia: Lippincott-Raven Publishers, 1996.
13. Hunt S, Mc Kewan J, Mc Kenna SP. The Nottingham Health Profile: User's Manual, 1981.
14. Ware JE, Sherbourne CD. A 36-item short form health survey (SF-36). I. Conceptual framework and item selection. Med Care 1992;30: 473-83.
15. Hays RD, Sherbourne C, Mazel E. The RAND 36-item health survey 1.0. Health Econ 1993;2: 217-27.
16. Smith DF, Baker GA, Dewey M, Jacoby A, Chadwick DW. Seizure frequency, patient-perceived seizure severity and the psychosocial consequences of intractable epilepsy. Epil Res. 1991;9:231-41.
17. Baker GA, Smith DF, Dewey M, Jacoby A, Chadwick DW. The initial development of a health-related quality of life model as an outcome measure in epilepsy. Epil Res 1993;16: 65-81.
18. Jacoby A, Baker GA, Dewey M, Chadwick DW Measuring the impact of epilepsy: the development of a novel scale. Epil Res 1993;16: 83-8.
19. Baker GA, Jacoby A, Smith DF, et al. Development of a novel scale to assess life fulfillment as part of the further refinement of a quality of life model for epilepsy. Epilepsia 1994;35: 591-6.
20. Chaplin JE, Yepez R, Shorvon S, Floyd M. A quantitative approach to measuring the social effects of epilepsy. Neuroepidemiology 1990;9: 151-8.
21. Vickrey BG, Hays RD, Graber J, Rausch R, Engel J, Brook RH. A health-related quality of life instrument for patients evaluated for epilepsy surgery. Med Care. 1992;30: 299-319.
22. Devinsky O, Vickrey BG, Cramer JA, Perrine K, Hermann B, Meador K, Hays RD. Development of the quality of life in epilepsy (QOLIE) inventory. Epilepsia 1995;36: 1089-104.
23. Cramer JA, Perrine K, Devinsky O, Vickrey BG, Meador K, Hermann BP, Bryant-Comstock L. Development of a 31-item quality of life in epilepsy inventory (QOLIE-31) and cross-cultural translations. Epilepsia 1997;38. (in press).
24. Cramer JA, Perrine K, Devinsky O, Meador K. A brief questionnaire to screen for quality of life in epilepsy: The QOLIE-10. Epilepsia, 1996;37: 577-82.
25. Cramer JA, Devinsky O, Westbrook L, Perrine K, Hermann B, Camfield C, et al. Adaptation of an epilepsy quality of life instrument for adolescents. Epilepsia 1995;36 (Suppl. 4): 93.
26. Wagner AK, Keller SD, Kosinski M, Baker GA, Jacoby A, Hsu MA, et al. Advances in methods for assessing the impact of epilepsy and antiepileptic drug therapy on patients' health-related quality of life. QOL Res 1995;4: 115-34.
27. Smith D, Baker G, Davies G, et al. Outcomes of add-on treatment with lamotrigine in partial epilepsy. Epilepsia 1993;34: 312-22.
28. Vickrey BG, Hays RD, Engel J, Spritzer K, Rogers WH, Rausch R, et al. Outcome assessment for epilepsy surgery: The impact of measuring health-related quality of life. Ann Neurol 1995;37: 158-66.
29. Johnson A. Some statistical issues in quality of life measurements. In: Trimble MR, Dodson WE, eds. Epilepsy and Quality of Life. New York: Raven Press. 1994: 65-84.
30. Cockerell OC, Hart YM, Sander JWAS, et al. The cost of epilepsy in the United Kingdom: An estimation based on the results of two population-based studies. Epil Res 1994;18: 249-60.
31. Begley CE, Annegers JF, Lairson DR, et al. Cost of epilepsy in the United States: A model base on incidence and prognosis. Epilepsia 1994;35: 1230-43.